Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 1;21(3):269-277.
doi: 10.1097/ACI.0000000000000743.

Wheat oral immunotherapy

Stephanie Leeds  1 , Elise G Liu  2 , Anna Nowak-Wegrzyn  3   4
Affiliations
Review

Wheat oral immunotherapy

Stephanie Leeds et al. Curr Opin Allergy Clin Immunol. .

Abstract

Purpose of review: The prevalence of food allergy is increasing on a global scale, and therefore increased attention is being paid to specific food allergy epidemiology and management. There has been a large amount of progress made in the last decade on human trials of wheat oral immunotherapy (WOIT).

Recent findings: To date, there has been one multicenter, double-blind, randomized controlled trial of WOIT, one randomized, noncontrolled trial of WOIT, and several smaller, nonrandomized clinical trials of WOIT. WOIT trials are generally limited by smaller sample sizes, affecting the demographic skew of evaluated patients. In addition, there is minimal standardization of efficacy and safety outcomes between trial protocols, making head-to-head comparison challenging. However, some common themes emerge. The majority of WOIT regimens result in successful desensitization, and success is more likely with higher maintenance dosing for longer periods of time. Limited studies have looked at sustained unresponsiveness in WOIT. WOIT can induce allergic reactions, including anaphylaxis, but more severe reactions often have an associated augmenting factor, such as exercise. Lower maintenance doses likely are associated with less severe reactions, and food modification and/or adjunct therapeutics may also decrease the risk of reactions.

Summary: WOIT trials are ongoing and will optimize updosing protocols and maintenance doses to improve efficacy and safety.

PubMed Disclaimer

References

    1. Ebisawa M, Ito K, Fujisawa T. Japanese guidelines for food allergy. Allergol Int 2017; 66:248–264.
    1. Morita E, Chinuki Y, Takahashi H, et al. Prevalence of wheat allergy in Japanese adults. Allergol Int 2012; 61:101–105.
    1. Imamura T, Kanagawa Y, Ebisawa M. A survey of patients with self-reported severe food allergies in Japan. Pediatr Allergy Immunol 2008; 19:270–274.
    1. Gupta RS, Warren CM, Smith BM, et al. Prevalence and severity of food allergies among US adults. JAMA Network Open 2019; 2:e185630 doi: 10.1001/jamanetworkopen.2018.5630. - DOI
    1. Gupta RS, Springston EE, Warrier MR, et al. The prevalence, severity, and distribution of childhood food allergy in the United States. Pediatrics 2011; 128:e9–e17.

Publication types